Central Nervous System
Resources
These guidelines were developed as a collaborative effort of the Nursing Discipline and the Late Effects Committee and are maintained and updated by the Children’s Oncology Group’s Long-Term Follow-Up Guidelines Core Committee and its associated Task Forces.
Late Effects of the Central Nervous system at the National Cancer Institute
Brain Tumour Foundation for Children, Inc: www.braintumorkids.org
Brain Tumour Foundation of Canada: www.braintumour.ca
Childhood Brain Tumor Foundation: www.childhoodbraintumor.org
Children’s Brain Tumor Foundation: www.cbtf.org
The International Brain Tumour Alliance: www.theibta.org
Pediatric Brain Tumor Foundation of the United States: www.pbtfus.org
Pediatric Low-Grade Astroctyoma Foundation: www.fightplga.org
Pituitary Network Association: www.pituitary.org
References
1. Armstrong GT, Liu Q, Yasui Y, et al: Long-term outcomes among adult survivors of childhood central nervous system malignancies in the childhood cancer survivor study. J Natl Cancer Inst 101:946-958, 2009
2. Duffner PK: Risk factors for cognitive decline in children treated for brain tumors. European Journal of Paediatric Neurology 14:106-115, 2010
3. Duffner PK: Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors. Neurologist 10:293-310, 2004
4. Anderson FS, Kunin-Batson AS: Neurocognitive late effects of chemotherapy in children: The past 10 years of research on brain structure and function. Pediatr Blood Cancer 52:159-164, 2009
5. Pakakasama S, Veerakul G, Sosothikul D, et al: Late effects in survivors of childhood acute lymphoblastic leukemia: A study from thai pediatric oncology group. Int J Hematol 91:850-854, 2010
6. Duffner PK: Risk factors for cognitive decline in children treated for brain tumors. Eur J Paediatr Neurol 14:106-115, 2010
7. Buizer AI, Sonneville LMJd, Veerman AJP: Effects of chemotherapy on neurocognitive function in children with acute lymphoblastic leukemia: A critical review of the literature. Pediatric Blood & Cancer 52:447-454, 2009
8. Peterson CC, Johnson CE, Ramirez LY, et al: A meta-analysis of the neuropsychological sequelae of chemotherapy-only treatment for pediatric acute lymphoblastic leukemia. Pediatric Blood & Cancer 51:99-104, 2008
9. Banerjee J, Paakko E, Harila M, et al: Radiation-induced meningiomas: A shadow in the success story of childhood leukemia. Neuro-oncol 11:543-549, 2009
10. Mulhern RK, White HA, Glass JO, et al: Attentional functioning and white matter integrity among survivors of malignant brain tumors of childhood. J Int Neuropsychol Soc 10:180-189, 2004
11. Paakko E, Harila-Saari A, Vanionpaa L, et al: White matter changes on MRI during treatment in children with acute lymphoblastic leukemia: Correlation with neuropsychological findings. Medical & Pediatric Oncology 35:456-461, 2000
12. Mulhern RK, Palmer SL, Merchant TE, et al: Neurocognitive consequences of risk-adapted therapy for childhood medulloblastoma. Journal of Clinical Oncology 23:5511-5519, 2005
13. Mulhern RK, Palmer SL, Reddick WE, et al: Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. Journal of Clinical Oncology 19:472-479, 2001
14. Morris B, Partap S, Yeom K, et al: Cerebrovascular disease in childhood cancer survivors: A children's oncology group report SYMBOL. Neurology 73:1906-1913, 2009
15. Liu AK, Bagrosky B, Fenton LZ, et al: Vascular abnormalities in pediatric craniopharyngioma patients treated with radiation therapy. Pediatr Blood Cancer 52:227-230, 2009
